Hyperfine, Inc.

Hyperfine, Inc. completed its business combination with HealthCor Catalio Acquisition Corp (Nasdaq: HCAQ), a blank-check company sponsored by HealthCor Catalio Management, in December 2021. HealthCor Catalio Acquisition Corp conducted its initial public offering in 2021, targeting opportunities in the healthcare and life sciences sector. Hyperfine, which develops portable magnetic resonance imaging technology for clinical and point-of-care settings, filed the June 2023 8-K with the Securities and Exchange Commission under accession number 0000950170-23-027473 as part of its ongoing public-company reporting obligations following the de-SPAC transaction. The combined company trades on Nasdaq under the ticker HYPR. For full filing history, deal terms, and real-time status updates on Hyperfine and hundreds of other SPAC transactions, sign up for complete access at SpacDesk.